The present invention relates to a lattice microstructure made of an ultra-violet (“UV”) curable monomer that is formed into various footwear components, padding, and other protective equipment. The lattice structure has different structural properties in targeted regions of the structure.
Lattice microstructures are arrays of beams and trusses arranged three-dimensionally (“3D”) in crisscrossed and/or diagonal patterns. Various geometries can be used depending on the application of the lattice. For uses requiring strength and support, a close-knit structure is preferred. For uses requiring some flexibility, patterns with trusses spaced apart are preferred.
There are notable methods of creating 3D microstructures. One such method is stereolithography, which is a bottom-up, layer-by-layer approach.
Another method utilizes one or a few optical waveguides, in which an initial area of polymerization in a photo-sensitive monomer will trap a light and guide it to a tip of the polymerized region due to an index of refraction change.
The concept of using 3D printing technology in footwear has been investigated in certain specific applications. For example, 3D printed material formed having a lattice structure has been used as a midsole. In some applications, to attain the necessary flexibility, the lattice structure is formed with various gaps and breakage in the structure, which results in a non-uniform lattice structure.
Other attempts to use 3D printing in midsoles are described in U.S. Pat. No. 6,763,611. In this application, the midsole has a lattice structure with a plurality of connectors and masses to attenuate and distribute ground reaction forces as a person walks, but the structure is not a microstructure and there is no description of forming the structure from a UV curable monomer with varying strength and flexibility properties. There is also no suggestion to incorporate the lattice structure into other parts of the footwear, such as the upper, tongue, vamp, eyelets, and eye stays.
U.S. Pat. No. 8,726,540 describes footwear with a sole having a grid pattern, in which channels are disposed in the pattern to promote flow of loose water off the sole, but there is no description of forming the structure from a UV curable monomer with varying strength, flexibility, and permeability in targeted regions of the structure.
European Patent App. No. 2,777,420 describes a shoe with a lattice midsole having a plurality of zones, each zone differing from one another in height to promote improved foot movement. The lattice midsole is made of a nylon polymer, but there is no description of forming the structure from a UV curable monomer and no description or suggestion of additional properties of their lattice midsole, other than providing varied height in the structures.
U.S. Pat. No. 5,632,057 describes a method of making orthotic devices for footwear using UV curing technology, in which light of a particular wavelength from a light source passes through a light table to cure a conformable device around a person's foot, but there is no description of a microlattice structure with different utilizations for footwear, padding, and insulation.
U.S. Pat. No. 9,017,806 describes a lattice microstructure with microstruts extending in different directions and sandwiched between two platforms to form a shoe insole, but there is no description or suggestion to incorporate the lattice microstructure into other shoe components. There are also no specifics given regarding how to use lattice microstructures for padding or insulation, such as a particular shape or structure.
Thus, is may be desirable to utilize lattice microstructures formed from a UV curable monomer with varying strength, flexibility, and permeability in targeted regions of the structure to produce other shoe components, such as the upper, tongue, vamp, quarters, and/or closure systems (i.e., laces), in a quick and efficient manner and with tunable properties ranging from strong, durable, flexible, and breathable.
The terms “invention,” “the invention,” “this invention” and “the present invention” used in this patent are intended to refer broadly to all of the subject matter of this patent and the patent claims below. Statements containing these terms should be understood not to limit the subject matter described herein or to limit the meaning or scope of the patent claims below. Embodiments of the invention covered by this patent are defined by the claims below, not this summary. This summary is a high-level overview of various aspects of the invention and introduces some of the concepts that are further described in the Detailed Description section below. This summary is not intended to identify key or essential features of the claimed subject matter, nor is it intended to be used in isolation to determine the scope of the claimed subject matter. The subject matter should be understood by reference to appropriate portions of the entire specification of this patent, any or all drawings and each claim.
According to certain embodiments of the present invention, an upper for a sports shoe comprises: a vamp comprising a UV curable microlattice structure comprising a plurality of regions such that each region comprises a different density.
In some embodiments, the plurality of regions comprises at least two of an eye stay region, a structural panel, and a non-structural region.
In certain embodiments, the plurality of regions comprises an eye stay region, a structural panel, and a non-structural region.
The eye stay region, in some embodiments, comprises a high density microlattice structure, the structural panel comprises a mid-level density microlattice structure, and the non-structural region comprises a low density microlattice structure.
In certain embodiments, the structural panel is disposed between the eye stay region and the bottom of the vamp, and the non-structural region is disposed adjacent to the structural panel.
The vamp, in certain embodiments, comprises a transition between the UV curable microlattice structure and a second material. In some embodiments, the second material is selected from the group consisting of knits, woven fabric, non-woven fabric, leather, and synthetic leather.
In some embodiments, the plurality of regions of the vamp each comprise a different color or pattern created by additives impregnated into each region.
According to certain embodiments of the present invention, an upper for a sports shoe comprises: a rear portion comprising a UV curable microlattice structure comprising a plurality of regions such that each region comprises a different density.
In certain embodiments, the plurality of regions comprises at least two of a collar, a heel counter, and a padding region. In some embodiments, the plurality of regions comprises a collar, a heel counter, and a padding region. In certain embodiments, the heel counter comprises a high density microlattice structure, the collar comprises a mid-level density microlattice structure, and the padding region comprises a low density microlattice structure.
The rear portion, in some embodiments, comprises a transition between the UV curable microlattice structure and a second material. In certain embodiments, the second material is selected from the group consisting of knits, woven fabric, non-woven fabric, leather, and synthetic leather.
In some embodiments, the plurality of regions of the rear portion each comprise a different color or pattern created by additives impregnated into each region.
According to certain embodiments of the present invention, a method of forming an upper of a microlattice structure for a shoe comprises: pouring resin into a chamber; passing ultraviolet light through a mask into the resin along light paths defined by the mask to create an upper with portions of at least two different densities; disassembling the upper in a green state from the chamber; and post curing the upper into a final shape outside of the chamber.
The method of forming an upper of a microlattice structure for a shoe, in certain embodiments, further comprises mapping and designing various components of the upper and designing the mask based on the upper.
In some embodiments, the post curing comprises using a mold to define a permanent shape for the upper.
The method of forming an upper of a microlattice structure for a shoe, in some embodiments, further comprises forming a transition between the microlattice structure and a second material. In certain embodiments, the second material is selected from the group consisting of knits, woven fabric, non-woven fabric, leather, and synthetic leather.
The method of forming an upper of a microlattice structure for a shoe, in some embodiments, further comprises impregnating additives into a plurality of regions of the upper to create different colors or patterns.
In the following detailed description, embodiments of the invention are described referring to the following Figures:
The subject matter of embodiments of the present invention is described here with specificity to meet statutory requirements, but this description is not necessarily intended to limit the scope of the claims. The claimed subject matter may be embodied in other ways, may include different elements or steps, and may be used in conjunction with other existing or future technologies. This description should not be interpreted as implying any particular order or arrangement among or between various steps or elements except when the order of individual steps or arrangement of elements is explicitly described.
Footwear Components Comprising a Microlattice Structure
According to certain embodiments of the present invention, footwear components 10, such as uppers, tongues, vamps, quarters, toe boxes, front portion, rear portion, and/or eye stays, are formed of a microlattice structure 12. In certain embodiments, as shown in
In these embodiments, the microlattice structure 12 is an array of beams and trusses arranged three-dimensionally. The relative density (ρr) of a microlattice structure is defined as the density of the lattice (ρ) divided by the density of the constituent solid (ρs), ranging from 0.2 to 0.02%. Relative density is a geometric parameter that defines the amount of empty space in a lattice.
The relative density of the microlattice structure 12 may be increased by increasing the number of beams and trusses within a 3D space, thereby creating a more close-knit structure. Microlattice structures 12 with higher relative densities provide a stiffer structure with greater resilience and stability. The relative density may be controlled using a combination of one or more of the chemistry of the monomer, the geometry of the lattice, additives/coatings on the lattice, and/or any other appropriate variable.
As shown in
Conversely, relative density of the microlattice structure 12 may be decreased by decreasing the number of beams and trusses within a 3D space, thereby creating a more open-knit structure. Microlattice structures 12 with lower relative densities provide flexibility, permeability, and/or breathability. Changing the density of the microlattice structure 12 allow a shoe (such as a sports shoe) or a portion of a shoe to be particularly designed to optimize multiple properties including, but not limited to strength, breathability, permeability, resilience, stability, and flexibility. In some embodiments, relative density can be adjusted through changes to at least one of the chemical composition of the monomer, the geometry of lattice, and the additives/coatings on the lattice.
In some embodiments, relative densities are selected in relation to the required mechanical properties of the components. Components such as eye stays and portions of midfoot 24 may require higher density because they hold the wearer's foot under higher tensile loads. Generally, central areas have higher densities to provide protection against lace-bite, and edges to provide shape, contour, and tear resistance. Some portions of the vamp and tongue components may include lower density because these components are not subject to the same load conditions and do not provide as much support for the wearer's foot. These components may be arranged to provide exposure for permeability and ventilation.
In certain embodiments, parametric design and/or generative design may be utilized to design and/or customize the microlattice structure 12 based on specific loading conditions and/or specific geometry of an wearer's foot. In addition, parametric design and/or generative design may be utilized to design and/or customize a Biaxially-oriented polyethylene terephthalate (BoPET) mask that may be used to create the microlattice structure 12. The mask may be constructed from any appropriate material. In some embodiments, the mask may be Mylar®. Parametric design uses certain parameters or variables that can be edited to manipulate or alter the end result of a system. In some embodiments, when using FEA, forces applied on a person's foot are predicted, measured, and analyzed to design the mask used to help form the UV curable upper. Generative designing may use a set of algorithms to generate outputs, such as images, sounds, architectural models, and/or animations. This technique may also be used in creating the mask used for producing UV curable patterns.
In certain embodiments of the present invention, the footwear component 10 comprises a microlattice structure 12 comprising at least one region of higher relative density 14 and at least one region of lower relative density 16.
In certain embodiments where the footwear component 10 is an upper 18, the at least one region of higher relative density 14 may be arranged in regions requiring greater resilience and stability, including but not limited to eye stays 17, toe box 23, heel cup, and medial/lateral supports. In addition, the at least one region of lower relative density 16 may be arranged in regions requiring greater flexibility, permeability, and/or breathability, including but not limited to the vamp and tongue. The relative density may be selected in proportion to the desired level of support.
As shown in
In certain embodiments where the footwear component is a vamp 22, as shown in
As shown in
In some embodiments, a forward portion of an upper may include a toe box 23 and a toe structural member 19. In some embodiments, the toe box 23 and toe structural member 19 each comprise microlattice structures 12. In certain embodiments, the components in the forward portion of the upper comprise two or more different densities of microlattice structures 12. In some examples, the structural member 19 comprises microlattice structures 12 with a high density and the toe box 23 comprises microlattice structures 12 with a mid-level and/or low density. The structural member 19 ensures that the forces from a wearer's toes are appropriately distributed through the upper and/or into the sole.
The microlattice structures 12 may be combined with other materials 50 including but not limited to knits, woven fabric, non-woven fabric, leather, or synthetic leather to form the footwear component. For example, the microlattice structures 12 may be used in areas where high breathability and permeability are desired (such as in the tongue, vamp, and other areas where sweat and heat dispersion most occur), and the other materials 50 may be used in areas where greater rigidity and support are needed (such as in the toe area, heel area, medial/lateral side supports). As shown in
The microlattice structures 12 may further include a range of colorations to impart different colorations and patterns on the footwear components 10. The process of adding color to the microlattice structures 12 is similar to that of coloring light emitting diodes (“LEDs”). For example, AURA® Infusion was developed by Bayer® MaterialScience and is licensed exclusively to Omnifusion. In this step, organic additives are impregnated into the polymer, then rinsed and dried. This step takes about 30-60 seconds to complete. Masks 850 of various designs and patterns may be applied on uppers to create different colorations. Furthermore, components of the upper can be colored independently. Alternatively, and/or in addition, other methods of coloration may be utilized to impart various colors and patterns on portions of footwear components 10. Examples include, but are not limited to, painting, coating, conventional dying, anodization, and metallization.
In some embodiments, the microlattice structures 12 may be used to replace footwear upper components 10 made from traditional and/or 3D printing/rapid-prototyping. The types of footwear components 10 that may be replaced include but are not limited to tongue and tongue padding, toe box 23, vamp, lace bite protection, heel counters 26 and heel padding, a collar 27 for comfort, other padding or protection areas, midsoles, sprint plates, and sockliners for letting air flow under the foot. Likewise, the microlattice structure 12 may be used in place of conventional materials used for insulation and golf coverings. In these embodiments, depending on the replacement application, the microlattice structures 12 may comprise at least one region of higher relative density 14 and at least one region of lower relative density 16, as described above. In certain applications, the microlattice structures 12 may comprise a uniform relative density, particularly in applications where the microlattice structures 12 are being used as cushioning components.
Microlattice structures may be formed or molded over shapes when in their “green state” (right after they are taken out of the bath). The microlattice structures may later be post-cured (using a UV source) such that the microlattice structures will keep the molded shape permanently. The microlattice structures may be sufficiently flexible to temporarily adjust to a different shape but can be used for a “spring back” effect to return to the molded shape. When a molded shape is elastically deformed, it will creep back to its original molded shape. Based on the geometric and other properties of the microlattice structures, the “creep back” effect occurs slowly like a mechanical system in an overdamped condition. The “spring back” effect or “creep back” effect could be used to articulate (or animate) sections of a footwear upper. As shown in
Method of Forming Footwear Components Comprising a Microlattice Structure
According to certain embodiments of the present invention, a method of manufacturing footwear components comprises using UV light and UV curable monomers to create microlattice structures with at least one region of higher relative density and at least one region of lower relative density. One way to adjust the density of the microlattice structure 12 is to change the spacing/distribution of the apertures in the mask. Examples of UV curable monomers include but are not limited to acrylates, urethanes, co-monomers.
As shown in
In some embodiments, to adjust relative density, specific areas of a shoe and/or an upper are designed to provide more or less support, breathability, and/or transparency (among other qualities). After mapping and designing the various portions of the shoe, a pattern is designed to correspond to the arrangement and the specific properties of the intended lattices. After the shape and structure of the pattern has been established, data (including for example, expected forces applied to the shoe) is analyzed for creating the special mask such that the analysis determines the lattices and their density.
As described above, altering the relative density of the microlattice structure 12 in certain locations within the footwear component 10 optimizes the performance of a shoe 28. For example, increasing the relative density of the microlattice structure 12 within the region 14 increases the rigidity and durability of the microlattice structure 10 in that region 14.
Conversely, decreasing the relative density of the microlattice structure 12 within the region 16 increases the breathability and flexibility of the microlattice structure 12 in that region 16. As shown in
The desired properties of the microlattice structure 12 are often governed by the type of footwear component 10 into which it is being incorporated and the function that will be performed. As an example, the microlattice structure 12 may be used to promote ventilation and breathability in various parts of the footwear, such as the vamp 22, tongue 20, or other zones of the upper 18.
Method of Forming Uppers with a 3D Cured Shape
In some embodiments, as outlined in
In some embodiments, during forming the upper 18, the lattice structure is removed from the bath while in its green state. The green state may be a state where the microlattice structure is a partially cured polymer lattice.
Once the upper 18 is partially cured in its green state, the upper 18 is draped over a last or mold 32 having the desired final shape of the upper 18. The upper 18 is then further cured an additional time to hold the shape of the last or mold 32. This additional curing typically requires approximately less than one minute under a light source. In some embodiments, the curing occurs in approximately 20 seconds under a UV light source. One example of a spherical or partially spherical mold 32 is shown in
This method reduces the need for extraneous packing materials. Presently, shoes need packing materials to maintain shape during transport and distribution, and to provide an aesthetic display for the customer. However, because a final shape of the upper may be defined using the mold and the shape/form of the UV curable footwear may be retained upon assembly, the footwear can be shipped without any extraneous packing or display materials.
Method of Forming Uppers Using Rolls of Microlattice Structures
In some embodiments, as outlined in
In some embodiments, as outlined in
In these embodiments, an upper pattern is integrally grown in a continuous sheet, which may be rolled for ease of handling and transporting. The microlattice structures are created to the desired shape of the component (such as, for example, the upper or a portion thereof). The lattices are grown based on the orientation and arrangement of the apertures in the mask. If the apertures are aligned and placed to make a shoe pattern shape, the microlattice will form following that shape. A mask design may be used to create the repetitive upper patterns on the rolls of microlattice structure templates. The mask design includes apertures.
The next step involves curing the repetitive upper patterns. This partial curing step typically requires approximately less than one minute.
Various methods for removing the newly formed uppers from the rolls include, but are not limited to die-cutting, knife-excising, laser-cutting, water-jet cutting, and hand removal. Furthermore, the mask can include a feature where it outlines perforations around the upper pattern, allowing for easy removal of the newly formed upper from the roll.
In some embodiments, a layer 901 of microlattice structures 12 may include a single density such that specific portions of the upper 18 are cut from layer of material. As one example,
Different arrangements of the components depicted in the drawings or described above, as well as components and steps not shown or described are possible. Similarly, some features and sub-combinations are useful and may be employed without reference to other features and sub-combinations. Embodiments of the invention have been described for illustrative and not restrictive purposes, and alternative embodiments will become apparent to readers of this patent. Accordingly, the present invention is not limited to the embodiments described above or depicted in the drawings, and various embodiments and modifications may be made without departing from the scope of the claims below.
This application is a continuation of U.S. patent application Ser. No. 16/023,881, filed on Jun. 29, 2018, entitled “UV CURABLE LATTICE MICROSTRUCTURE FOR FOOTWEAR” (Allowed), which is a divisional of U.S. patent application Ser. No. 15/184,470, filed on Jun. 16, 2016, entitled “UV CURABLE LATTICE MICROSTRUCTURE FOR FOOTWEAR” (Issued), which are hereby incorporated herein in their entirety by this reference.
Number | Name | Date | Kind |
---|---|---|---|
2131756 | Roberts | Oct 1938 | A |
2294424 | Roberts | Sep 1942 | A |
2684305 | Leroy | Jul 1954 | A |
3250840 | Oreste | May 1966 | A |
3399470 | Schofield | Sep 1968 | A |
4611412 | Cohen | Sep 1986 | A |
5275372 | Boeckeler | Jan 1994 | A |
5389176 | Nakanishi et al. | Feb 1995 | A |
5632057 | Lyden | May 1997 | A |
5758435 | Miyata | Jun 1998 | A |
5763049 | Frey et al. | Jun 1998 | A |
6551531 | Ford et al. | Apr 2003 | B1 |
6655048 | Moretti et al. | Dec 2003 | B2 |
6763611 | Fusco et al. | Jul 2004 | B1 |
6939502 | Lyden et al. | Sep 2005 | B2 |
7003803 | Lyden et al. | Feb 2006 | B1 |
7695668 | Takahashi et al. | Apr 2010 | B2 |
7732513 | Jimbo | Jun 2010 | B2 |
7774884 | Greene et al. | Aug 2010 | B2 |
7836608 | Greene et al. | Nov 2010 | B2 |
8065818 | Hoke et al. | Nov 2011 | B2 |
8109757 | Fusi, III | Feb 2012 | B1 |
8344070 | Squire et al. | Jan 2013 | B2 |
8398903 | Hagmann et al. | Mar 2013 | B2 |
8578535 | Dojan et al. | Nov 2013 | B2 |
8726540 | Crowley, II et al. | May 2014 | B2 |
8826566 | Crowley, II et al. | Sep 2014 | B2 |
9017806 | Manning et al. | Apr 2015 | B2 |
9405067 | Yang et al. | Aug 2016 | B2 |
9527261 | Roper et al. | Dec 2016 | B1 |
10034519 | Lussier | Jul 2018 | B2 |
10801351 | Rugg et al. | Oct 2020 | B2 |
20020018281 | Theiste et al. | Feb 2002 | A1 |
20040004300 | Yamaguchi et al. | Jan 2004 | A1 |
20040087754 | Foley et al. | May 2004 | A1 |
20040143034 | Primke et al. | Jul 2004 | A1 |
20050056954 | Devlin et al. | Mar 2005 | A1 |
20060048413 | Sokolowski et al. | Mar 2006 | A1 |
20060194707 | Lu | Aug 2006 | A1 |
20070180730 | Greene et al. | Aug 2007 | A1 |
20070204482 | Gibson-Collinson | Sep 2007 | A1 |
20080033112 | Squire et al. | Feb 2008 | A1 |
20090126225 | Jarvis | May 2009 | A1 |
20090302507 | Tsunozaki et al. | Dec 2009 | A1 |
20120021151 | Tatarka et al. | Jan 2012 | A1 |
20120117825 | Jarvis et al. | May 2012 | A9 |
20120144698 | McDowell | Jun 2012 | A1 |
20120167418 | Frappier et al. | Jul 2012 | A1 |
20120180341 | Crowley et al. | Jul 2012 | A1 |
20130134636 | Schneider et al. | May 2013 | A1 |
20130273347 | Jacobsen et al. | Oct 2013 | A1 |
20140020191 | Jones et al. | Jan 2014 | A1 |
20140020192 | Jones et al. | Jan 2014 | A1 |
20140026773 | Miller et al. | Jan 2014 | A1 |
20140029030 | Miller et al. | Jan 2014 | A1 |
20140130270 | Baudouin et al. | May 2014 | A1 |
20140134378 | Downs et al. | May 2014 | A1 |
20140299009 | Miller et al. | Oct 2014 | A1 |
20140300675 | Miller et al. | Oct 2014 | A1 |
20140300676 | Miller et al. | Oct 2014 | A1 |
20140310986 | Tamm et al. | Oct 2014 | A1 |
20150013187 | Taniguchi et al. | Jan 2015 | A1 |
20150111979 | Yang et al. | Apr 2015 | A1 |
20150298443 | Hundley et al. | Oct 2015 | A1 |
20150328512 | Davis et al. | Nov 2015 | A1 |
20160007687 | Surace et al. | Jan 2016 | A1 |
20160021969 | Lettow, II et al. | Jan 2016 | A1 |
20160103255 | Powell et al. | Apr 2016 | A1 |
20160227876 | Le et al. | Aug 2016 | A1 |
20160242505 | Waatti et al. | Aug 2016 | A1 |
20160290144 | Roussille et al. | Oct 2016 | A1 |
20160295971 | Arnese et al. | Oct 2016 | A1 |
20160346626 | Hanson et al. | Dec 2016 | A1 |
20160362552 | Reichel et al. | Dec 2016 | A1 |
20160374428 | Kormann et al. | Dec 2016 | A1 |
20170181496 | Guyan et al. | Jun 2017 | A1 |
20170202309 | Sterman et al. | Jul 2017 | A1 |
20170360156 | Lussier | Dec 2017 | A1 |
20190329457 | Miyake et al. | Oct 2019 | A1 |
20190331127 | Foster et al. | Oct 2019 | A1 |
20200094447 | Blaney et al. | Mar 2020 | A1 |
20200299200 | Sheedy et al. | Sep 2020 | A1 |
20210079804 | Clark et al. | Mar 2021 | A1 |
Number | Date | Country |
---|---|---|
1067566 | Jan 1993 | CN |
1085756 | Apr 1994 | CN |
102529287 | Jul 2012 | CN |
102711538 | Oct 2012 | CN |
103561929 | Feb 2014 | CN |
104859277 | Aug 2015 | CN |
105636993 | Jun 2016 | CN |
106418874 | Feb 2017 | CN |
19753863 | Jun 1998 | DE |
102004045176 | Mar 2006 | DE |
102015209811 | Dec 2016 | DE |
102015212099 | Dec 2016 | DE |
0137888 | Apr 1985 | EP |
185781 | Jun 1988 | EP |
1378898 | Jan 2004 | EP |
1434211 | Jun 2004 | EP |
1484148 | Dec 2004 | EP |
1872924 | Jan 2008 | EP |
2424398 | Mar 2012 | EP |
2441338 | Apr 2012 | EP |
2564719 | Mar 2013 | EP |
2671703 | Dec 2013 | EP |
2744744 | Jun 2014 | EP |
2777420 | Sep 2014 | EP |
2838708 | Feb 2015 | EP |
3053732 | Aug 2016 | EP |
2494131 | Jan 2014 | GB |
03045902 | Feb 1991 | JP |
2004021817 | Mar 2004 | WO |
2006031003 | Mar 2006 | WO |
2007006652 | Jan 2007 | WO |
2010126707 | Nov 2010 | WO |
2010126708 | Nov 2010 | WO |
2012170008 | Dec 2012 | WO |
2014008331 | Jan 2014 | WO |
2014015033 | Jan 2014 | WO |
2014015037 | Jan 2014 | WO |
2014036124 | Mar 2014 | WO |
2014100462 | Jun 2014 | WO |
2014209308 | Dec 2014 | WO |
2016089462 | Jun 2016 | WO |
2017007533 | Jan 2017 | WO |
Entry |
---|
U.S. Appl. No. 15/184,470, Non Final Office Action, dated Nov. 22, 2017, 9 pages. |
U.S. Appl. No. 15/184,470, Notice of Allowance, dated Apr. 3, 2018, 5 pages. |
U.S. Appl. No. 16/023,881, Non-Final Office Action, dated Jul. 10, 2020, 14 pages. |
U.S. Appl. No. 16/023,881, Notice of Allowance dated Mar. 11, 2021, 11 pages. |
Chinese Patent Application No. 201710455737.6, Office Action dated Aug. 28, 2019, 20 pages (English machine translation provided). |
Chinese Patent Application No. 201710455737201710455737.6, Office Action dated Apr. 1, 2020, 9 pages (English machine translation provided). |
European Patent Application No. 20171045573717175040.9, Extended European Search Report dated Oct. 20, 2017, 5 pages. |
European Patent Application No. 18209551.3, Extended European Search Report dated Mar. 13, 2019, 7 pages. |
Thomas, G.P., “Braided Fibers-Manufacturing, Benefits and Applications”, AZO Materials, retrieved at https://www.azom.com/article.aspx?ArticleID=8383, Apr. 10, 2013, 5 pages. |
Chinese Application No. 202110188156.7, Office Action dated Apr. 25, 2022, 9 pages. (4 pages of Original Document and 5 pages of English Translation). |
European Application No. 17175040.9, Decision to Grant dated Nov. 8, 2018, 1 page. |
Number | Date | Country | |
---|---|---|---|
20210330034 A1 | Oct 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15184470 | Jun 2016 | US |
Child | 16023881 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16023881 | Jun 2018 | US |
Child | 17371814 | US |